{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Duramorph+300&page=2", "query": { "intervention": "Duramorph 300", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Duramorph+300&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-12T05:38:33.213Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01871285", "title": "Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pain" ], "interventions": [ { "name": "Buprenorphine", "type": "DRUG" }, { "name": "Placebo film", "type": "DRUG" }, { "name": "Oxycodone", "type": "DRUG" }, { "name": "Morphine sulfate", "type": "DRUG" }, { "name": "Placebo capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioDelivery Sciences International", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 39, "start_date": "2013-06", "completion_date": "2014-07", "has_results": true, "last_update_posted_date": "2017-02-27", "last_synced_at": "2026-09-12T05:38:33.213Z", "location_count": 3, "location_summary": "Overland Park, Kansas • Philadelphia, Pennsylvania • Salt Lake City, Utah", "locations": [ { "city": "Overland Park", "state": "Kansas" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT01871285" }, { "nct_id": "NCT04544436", "title": "A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Multiple Sclerosis" ], "interventions": [ { "name": "Ocrelizumab", "type": "DRUG" }, { "name": "Antihistamine", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 864, "start_date": "2020-11-26", "completion_date": "2028-08-31", "has_results": true, "last_update_posted_date": "2026-07-30", "last_synced_at": "2026-09-12T05:38:33.213Z", "location_count": 25, "location_summary": "Cullman, Alabama • Homewood, Alabama • Phoenix, Arizona + 22 more", "locations": [ { "city": "Cullman", "state": "Alabama" }, { "city": "Homewood", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Carlsbad", "state": "California" }, { "city": "Stanford", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04544436" }, { "nct_id": "NCT03606460", "title": "A Study to Evaluate the Safety of Administering Ocrelizumab Per a Shorter Infusion Protocol in Participants With Primary Progressive Multiple Sclerosis (PPMS) and Relapsing Multiple Sclerosis (RMS)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Multiple Sclerosis" ], "interventions": [ { "name": "Ocrelizumab Dose 1", "type": "DRUG" }, { "name": "Ocrelizumab Dose 2 and Dose 3", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 141, "start_date": "2018-09-14", "completion_date": "2019-05-31", "has_results": true, "last_update_posted_date": "2020-06-29", "last_synced_at": "2026-09-12T05:38:33.213Z", "location_count": 5, "location_summary": "Aurora, Colorado • Wellesley, Massachusetts • Cleveland, Ohio + 2 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "Wellesley", "state": "Massachusetts" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT03606460" }, { "nct_id": "NCT02044094", "title": "Multiple Dose Study of Blockade of Opioid Effects by Injections of Buprenorphine in Participants With Opioid Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Opioid Use Disorder" ], "interventions": [ { "name": "Buprenorphine", "type": "DRUG" }, { "name": "buprenorphine and naloxone", "type": "DRUG" }, { "name": "hydromorphone", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Indivior Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 39, "start_date": "2013-11", "completion_date": "2014-07", "has_results": true, "last_update_posted_date": "2018-04-24", "last_synced_at": "2026-09-12T05:38:33.213Z", "location_count": 1, "location_summary": "Overland Park, Kansas", "locations": [ { "city": "Overland Park", "state": "Kansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02044094" }, { "nct_id": "NCT01402375", "title": "Comparing the Efficacy of Oral Opioids for Outpatient Acute Pain Management After ED Discharge Discharge", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Analgesia After ED Discharge for Extremity Injuries" ], "interventions": [ { "name": "Hydrocodone (first trial)", "type": "DRUG" }, { "name": "Codeine (first trial)", "type": "DRUG" }, { "name": "Oxycodone (for second trial)", "type": "DRUG" }, { "name": "Codeine (for second trial)", "type": "DRUG" }, { "name": "Oxycodone (third trial)", "type": "DRUG" }, { "name": "Hydrocodone (third trial)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Montefiore Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "21 Years to 64 Years" }, "enrollment_count": 720, "start_date": "2012-01", "completion_date": "2014-11", "has_results": true, "last_update_posted_date": "2018-05-01", "last_synced_at": "2026-09-12T05:38:33.213Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT01402375" }, { "nct_id": "NCT06935331", "title": "Prospective Opioid-Free AIS Fusion", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Adolescent Idiopathic Scoliosis (AIS)" ], "interventions": [ { "name": "Opioid-Free/Opioid-Avoidant", "type": "DRUG" }, { "name": "Opioid-Containing", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "OrthoCarolina Research Institute, Inc.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "10 Years to 20 Years" }, "enrollment_count": 58, "start_date": "2025-10-14", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-04-06", "last_synced_at": "2026-09-12T05:38:33.213Z", "location_count": 1, "location_summary": "Charlotte, North Carolina", "locations": [ { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT06935331" }, { "nct_id": "NCT07158476", "title": "Efficacy of Methylprednisolone for Pain Control After ACL Repair", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "ACL Surgery", "Pain Management" ], "interventions": [ { "name": "Meloxicam 15 mg", "type": "DRUG" }, { "name": "Medrol 4 MG Oral Tablet Includes Medrol Dosepak", "type": "DRUG" }, { "name": "Gabapentin 300 mg", "type": "DRUG" }, { "name": "Hydrocodone 5Mg/Acetaminophen 325Mg Tab", "type": "DRUG" }, { "name": "Ketorolac 10 Mg Oral Tablet", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "St. Louis University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "13 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "13 Years to 50 Years" }, "enrollment_count": 90, "start_date": "2025-10-21", "completion_date": "2031-09", "has_results": false, "last_update_posted_date": "2025-10-24", "last_synced_at": "2026-09-12T05:38:33.213Z", "location_count": 1, "location_summary": "St Louis, Missouri", "locations": [ { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT07158476" }, { "nct_id": "NCT05488847", "title": "Opioid-Free Pain Protocol After Shoulder Arthroplasty", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Shoulder Arthropathy", "Shoulder Pain" ], "interventions": [ { "name": "Celecoxib", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Dexamethasone", "type": "DRUG" }, { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Ropivicaine", "type": "DRUG" }, { "name": "Epinephrine", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Tizanidine", "type": "DRUG" }, { "name": "Magnesium", "type": "DRUG" }, { "name": "Ibuprofen", "type": "DRUG" }, { "name": "Oxycodone Hydrochloride 5 Mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Henry Ford Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 83, "start_date": "2022-06-25", "completion_date": "2026-09-01", "has_results": true, "last_update_posted_date": "2026-02-10", "last_synced_at": "2026-09-12T05:38:33.213Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05488847" }, { "nct_id": "NCT05053126", "title": "Study Evaluating Abuse Potential of Lyrica® in Healthy Non-Drug Dependent Recreational Opioid Users", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Abuse Potential" ], "interventions": [ { "name": "Pregabalin 300mg", "type": "DRUG" }, { "name": "pregabalin 450 mg", "type": "DRUG" }, { "name": "Pregabalin 300 mg with oxycodone 20 mg", "type": "DRUG" }, { "name": "pregabalin 450 mg with oxycodone 20 mg", "type": "DRUG" }, { "name": "oxycodone 20 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Viatris Specialty LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 60, "start_date": "2021-07-27", "completion_date": "2022-04-01", "has_results": true, "last_update_posted_date": "2023-08-14", "last_synced_at": "2026-09-12T05:38:33.213Z", "location_count": 1, "location_summary": "Marlton, New Jersey", "locations": [ { "city": "Marlton", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT05053126" }, { "nct_id": "NCT02958566", "title": "Multimodal Narcotic Limited Perioperative Pain Control With Colorectal Surgery", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Colon Cancer", "Colon Diverticulosis", "Colonic Neoplasms", "Colonic Diverticulitis", "Pain, Postoperative", "Ileus", "Ileus Paralytic", "Ileus; Mechanical", "Constipation Drug Induced", "Constipation", "Rectum Cancer", "Rectum Neoplasm" ], "interventions": [ { "name": "Acetaminophen", "type": "DRUG" }, { "name": "Gabapentin", "type": "DRUG" }, { "name": "Orphenadrine", "type": "DRUG" }, { "name": "Lidocaine", "type": "DRUG" }, { "name": "Marcaine", "type": "DRUG" }, { "name": "Ketamine", "type": "DRUG" }, { "name": "Methadone", "type": "DRUG" }, { "name": "Tramadol", "type": "DRUG" }, { "name": "Ketorolac", "type": "DRUG" }, { "name": "Morphine Sulfate", "type": "DRUG" }, { "name": "Fentanyl", "type": "DRUG" }, { "name": "Dilaudid", "type": "DRUG" }, { "name": "Hydrocodone-Acetaminophen Tab 5-325 MG", "type": "DRUG" }, { "name": "HYDROCODONE/ACETAMINOPHEN 5 Mg-325 Mg ORAL TABLET", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Illinois College of Medicine at Peoria", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 80, "start_date": "2017-01", "completion_date": "2018-12", "has_results": false, "last_update_posted_date": "2017-03-20", "last_synced_at": "2026-09-12T05:38:33.213Z", "location_count": 1, "location_summary": "Peoria, Illinois", "locations": [ { "city": "Peoria", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02958566" } ] }